| ID | 2077 |
| No | 2077 |
| Brand Name | LOSART 50 |
| Ingredients | LOSARTAN POTASSIUM USP 50 MG |
| Dosage Form | TABLET |
| Primary Packaging | ALU-PVC BLISTER |
| Storage | |
| Shelf Life | 3 YEARD |
| Pack Size | BOX OF 3 X 10'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | HYPERTENSION : LOSART IS INDICATED FOR THE TREATMENT OF HYPERTENSION. HYPERTENTIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY : LOSART IS INDICATED TO REDUCE THE RISK OF STROKE IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY. |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE TO OFF WHITE, ROUND, SEMI BI - CONVEX, FILM - COATED TABLETS ENGRAVED " ACME " ON ONE FACE AND A BREAKLINE ON THE OTHER FACE. |
| Note | |
| License Owner | PALAMY PHARMA CO., LTD |
| Manufacturer | THE ACME LABORATORIES LTD. |
| Country | BANGLADESH |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 03 I 4218/17 |
| FDD Registration Date | 19/05/2023 |
| Expiry Date | 18/05/2026 |